MindWalk Holdings Corp. (HYFT) Stock Score, Valuation & Financial Research

MindWalk Holdings Corp. is in the Healthcare sector and Biotechnology industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 21/100.

Quick answer for HYFT

MindWalk Holdings Corp. currently has a Wall Street Score of 21/100. The stored market price is $1.13. Its financial score is 23/100. Its valuation score is 0/100. The latest WSS change is +3.3 points. These figures are a research snapshot, not a buy or sell recommendation.

What MindWalk Holdings Corp. does

MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.

HYFT financial snapshot

Wall Street Score:
21/100
Current price:
$1.13
Market capitalization:
$53.1M
Revenue:
$11.1M
Net income:
$-9.9M
Free cash flow:
$-9.1M
Cash:
$8.1M
Total debt:
$2.5M
EPS:
-0.22
Financial score:
23/100
Valuation score:
0/100
Revenue score:
3/100

What stands out

  • Reported year-over-year revenue growth is +0.0%.
  • Free cash flow is $-9.1M, showing cash burn in the current stored period.
  • The balance sheet shows $8.1M of cash versus $2.5M of total debt, leaving more cash than debt.
  • The latest Wall Street Score change is +3.3 points: HYFT increased 3.3 points because Management improved by 40 points.

What the numbers mean

Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.

The financial score is 23/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-08-14.

How to research HYFT

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.